Abstract
The medical imaging segments are poised for a major new phase of growth fueled
by the availability of new technology coming out of the computer and digital
information technology segment. Continuous improvements in technology are
resulting in a growing number of new imaging tests that combine high levels of
accuracy with rapid, easy-to-use product formats. Part of that medical imaging
improvement is coming from positron emission tomography (PET). PET is a
scanning technique used in combination with small amounts of radio-labeled
compounds to visualize the anatomy and function of the brain. The purpose of
this TriMark Publications report is to describe the specific market segment of
the diagnostics medical imaging market called PET scanning. This sector
includes all of the generally accepted imaging activities that are currently
used in PET, including equipment for PET, PET/CT, SPECT and the use of
radiopharmaceuticals for imaging. It examines these clinical measurement
devices and their reagents and supplies as used in hospitals and clinics. It
also reviews associated clinical market segments in which PET scanning has
taken a prominent role including cancer treatment, cardiology, and neurology
imaging markets.
View Cart
